Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma

In patients with mild-to-moderate atopic asthma, IVL745 did not affect the early and late response to inhaled allergen or markers of airway inflammation, except for a modest reduction in sputum eosinophils.